October 8, 2013
EFPIA Japan Chairman Philippe Fauchet EFPIA Japan is ramping up its calls for the removal of a 14-day prescription limit, which is imposed on newly approved drugs regardless of their characteristics, on the back of Japanese health authorities’ initiatives to...read more